Iron chelators as antimalarials: The biochemical basis of selective cytotoxicity

Z. I. Cabantchik*

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

41 Scopus citations

Abstract

Like all living organisms, malaria parasites need iron for vital cell functions and must handle their cellular contents in a highly regulated fashion. However, in the asexual stage of growth, parasites present a special case of iron metabolism. Despite dwelling in a sea of hemoglobin and carrying inside the remnants of its degradation products, intracellular parasites have no obvious means for mobilizing bioavailable iron from the host or from the medium. In that sense they differ from most mammalian cells which are exposed to body fluids and acquire the metal from cirulating iron carriers. The uniqueness of iron handling by parasites is manifested in their susceptibility to drug-induced deprivation of the metal. Both natural and synthetic iron(III) chelators of the hydroxamate family have been shown to abolish cell growth in vitro, and to reduce malaria infection in vivo as well as in the clinic. Z. Ioav Cabantchik here explores the molecular basis for the selective cytotoxicity of iron(III) hydroxamate chelators and the potential of iron chelation therapy in the management of malaria.

Original languageEnglish
Pages (from-to)74-78
Number of pages5
JournalParasitology Today
Volume11
Issue number2
DOIs
StatePublished - 1995

Fingerprint

Dive into the research topics of 'Iron chelators as antimalarials: The biochemical basis of selective cytotoxicity'. Together they form a unique fingerprint.

Cite this